Sky Century Investment (SKYI) Amortizatization of Intangibles (2024 - 2026)
Sky Century Investment (SKYI) posted quarterly Amortizatization of Intangibles of $12227.0 for Q2 2026, down 1.58% year-over-year from $12423.0 in Q2 2025, and up 4.86% quarter-over-quarter from $11660.0 in Q1 2026.
Sky Century Investment (SKYI) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Amortizatization of Intangibles for 3 consecutive years, with $12227.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Amortizatization of Intangibles fell 1.58% year-over-year to $12227.0; the TTM figure through May 2026 stood at $59356.0 (up 33.98% YoY), while the FY2025 annual figure was $51859.0, up 49.57% from the prior year.
- Amortizatization of Intangibles improved to $12227.0 in Q2 2026 per SKYI's latest filing, from $11660.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $18459.0 in Q4 2025 and bottomed at $8407.0 in Q2 2024.
- Historically, Amortizatization of Intangibles has averaged $12451.7 across 3 years, with a median of $11660.0 in 2026.
- Annual changes were most pronounced in 2025 — Amortizatization of Intangibles soared 79.94% — and 2026, when it dropped 1.58%.
- Sky Century Investment's Amortizatization of Intangibles stood at $10781.0 in 2024, then surged by 71.22% to $18459.0 in 2025, then slumped by 33.76% to $12227.0 in 2026.
- Business Quant data shows SKYI's Amortizatization of Intangibles at $12227.0 in Q2 2026, $11660.0 in Q1 2026, and $18459.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 12,227.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 12,227.00 |
| May 31, 2026 | 12,227.00 |
| Feb 28, 2026 | 11,660.00 |
| Feb 28, 2026 | 11,660.00 |
| Nov 30, 2025 | 18,459.00 |
| Nov 30, 2025 | 18,459.00 |
| Aug 31, 2025 | 17,010.00 |
| Aug 31, 2025 | 17,010.00 |
| May 31, 2025 | 12,423.00 |
| May 31, 2025 | 12,423.00 |
| Feb 28, 2025 | 11,645.00 |
| Feb 28, 2025 | 11,645.00 |
| Nov 30, 2024 | 10,781.00 |
| Nov 30, 2024 | 10,781.00 |
| Aug 31, 2024 | 9,453.00 |
| Aug 31, 2024 | 9,453.00 |
| May 31, 2024 | 8,407.00 |
| May 31, 2024 | 8,407.00 |